Your browser doesn't support javascript.
loading
ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.
Froemming, Adam T; Verma, Sadhna; Eberhardt, Steven C; Oto, Aytekin; Alexander, Lauren F; Allen, Brian C; Coakley, Fergus V; Davis, Brian J; Fulgham, Pat F; Hosseinzadeh, Keyanoosh; Porter, Christopher; Sahni, V Anik; Schuster, David M; Showalter, Timothy N; Venkatesan, Aradhana M; Wang, Carolyn L; Remer, Erick M.
Afiliación
  • Froemming AT; Principal Author, Mayo Clinic, Rochester, Minnesota. Electronic address: froemming.adam@mayo.edu.
  • Verma S; Co-author, University of Cincinnati Medical Center, Cincinnati, Ohio.
  • Eberhardt SC; Panel Chair, University of New Mexico, Albuquerque, New Mexico.
  • Oto A; Panel Vice Chair, University of Chicago, Chicago, Illinois.
  • Alexander LF; Mayo Clinic, Jacksonville, Florida.
  • Allen BC; Duke University Medical Center, Durham, North Carolina.
  • Coakley FV; Oregon Health & Science University, Portland, Oregon.
  • Davis BJ; Mayo Clinic, Rochester, Minnesota.
  • Fulgham PF; Urology Clinics of North Texas, Dallas, Texas; American Urological Association.
  • Hosseinzadeh K; Wake Forest University School of Medicine, Winston Salem, North Carolina.
  • Porter C; Virginia Mason Medical Center, Seattle, Washington; American Urological Association.
  • Sahni VA; Brigham & Women's Hospital, Boston, Massachusetts.
  • Schuster DM; Emory University Hospital, Atlanta, Georgia.
  • Showalter TN; University of Virginia, Charlottesville, Virginia.
  • Venkatesan AM; University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang CL; University of Washington, Seattle Cancer Care Alliance, Seattle, Washington.
  • Remer EM; Specialty Chair, Cleveland Clinic, Cleveland, Ohio.
J Am Coll Radiol ; 15(5S): S132-S149, 2018 May.
Article en En | MEDLINE | ID: mdl-29724417
ABSTRACT
Diagnosis and management of prostate cancer post treatment is a large and complex problem, and care of these patients requires multidisciplinary involvement of imaging, medical, and surgical specialties. Imaging capabilities for evaluation of men with recurrent prostate cancer are rapidly evolving, particularly with PET and MRI. At the same time, treatment options and capabilities are expanding and improving. These recommendations separate patients into three broad categories (1) patients status post-radical prostatectomy, (2) clinical concern for residual or recurrent disease after nonsurgical local and pelvic treatments, and (3) metastatic prostate. This article is a review of the current literature regarding imaging in these settings and the resulting recommendations for imaging. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Guideline País/Región como asunto: America do norte Idioma: En Revista: J Am Coll Radiol Año: 2018 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Guideline País/Región como asunto: America do norte Idioma: En Revista: J Am Coll Radiol Año: 2018 Tipo del documento: Article